These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6847139)
41. [Retroperitoneal fibrosis secondary to treatment with L-dopa analogues for Parkinson disease]. Sánchez-Chapado M; Angulo Cuesta J; Guil Cid M; Jiménez FJ; López Alvarez YJ Arch Esp Urol; 1995 Dec; 48(10):979-83. PubMed ID: 8588730 [TBL] [Abstract][Full Text] [Related]
42. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias. Mark MH; Sage JI Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565 [TBL] [Abstract][Full Text] [Related]
43. [Treatment of parkinsonism with dopaminergic system agonists]. Dowzenko A Neurol Neurochir Pol; 1976; 10(4):579-82. PubMed ID: 958587 [No Abstract] [Full Text] [Related]
44. The response of "de novo" Parkinson's disease patients to bromocriptine in a "low and slow" regimen is predictive for prognosis. Sampaio C; Coelho T; Castro-Caldas A; Bastos-Lima A; Levy A J Neural Transm Suppl; 1995; 45():197-202. PubMed ID: 8748626 [TBL] [Abstract][Full Text] [Related]
45. Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients. Kuno S; Mizuta E; Yamasaki S; Araki I Parkinsonism Relat Disord; 2004 Mar; 10(3):181-7. PubMed ID: 15036175 [TBL] [Abstract][Full Text] [Related]
46. Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. Factor SA; Sanchez-Ramos JR; Weiner WJ J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):529-33. PubMed ID: 3288717 [TBL] [Abstract][Full Text] [Related]
47. Clinical studies with bromocriptine in idiopathic parkinsonism. Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483 [No Abstract] [Full Text] [Related]
48. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients. Serby M; Angrist B; Lieberman A Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908 [No Abstract] [Full Text] [Related]
49. Amantadine-induced myoclonus in a patient with progressive supranuclear palsy. Yarnall AJ; Burn DJ Age Ageing; 2012 Sep; 41(5):695-6. PubMed ID: 22421702 [TBL] [Abstract][Full Text] [Related]